Abbott Sues Impax Over Generic TriCor ANDA
Abbott Laboratories has launched another suit seeking to block a generic version of its cholesterol drug TriCor, this one targeting generics maker Impax Laboratories Inc....To view the full article, register now.
Already a subscriber? Click here to view full article